Literature DB >> 9224647

Cloning of mouse 17beta-hydroxysteroid dehydrogenase type 2, and analysing expression of the mRNAs for types 1, 2, 3, 4 and 5 in mouse embryos and adult tissues.

M V Mustonen1, M H Poutanen, V V Isomaa, P T Vihko, R K Vihko.   

Abstract

17beta-Hydroxysteroid dehydrogenases (17HSDs) are responsible for the conversion of low-activity sex steroids to more potent forms, and vice versa. 17HSD activity is essential for the biosynthesis of sex steroids in the gonads, and it is also one of the key factors regulating the availability of active ligands for sex-steroid receptors in various extragonadal tissues. In this study, we have characterized mouse 17HSD type 2 cDNA, and analysed the relative expression of 17HSD types 1, 2, 3, 4 and 5 mRNAs in mouse embryos and adult male and female tissues. The cDNA characterized has a open reading frame of 1146 bp, and encodes a protein of 381 amino acids with a predicted molecular mass of 41837 kDa. Northern-blot analysis of adult mouse tissues revealed that, of the different 17HSDs, the type 2 enzyme is most abundantly expressed. High expression of the enzyme, which oxidizes both testosterone and oestradiol, in several large organs of both sexes indicates that it is the isoform having the most substantial role in the metabolism of sex steroids. Interestingly, four of the five 17HSD enzymes were also detected by Northern blots of whole mouse embryos, and each of the enzymes showed a unique pattern of expression. The oestradiol-synthesizing type 1 enzyme predominates in early days of development embryonic day 7, but after that the oxidative type 2 enzyme becomes the predominant form of all 17HSDs. The data therefore suggest that there is transient oestradiol production in the early days of embryonic development, after which inactivation of sex steroids predominates in the fetus and placenta.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224647      PMCID: PMC1218546          DOI: 10.1042/bj3250199

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Differential estrogen substrate specificities for transiently expressed human placental 17 beta-hydroxysteroid dehydrogenase and an endogenous enzyme expressed in cultured COS-m6 cells.

Authors:  M Poutanen; M Miettinen; R Vihko
Journal:  Endocrinology       Date:  1993-12       Impact factor: 4.736

2.  Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity.

Authors:  L Wu; M Einstein; W M Geissler; H K Chan; K O Elliston; S Andersson
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

3.  Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA.

Authors:  H Peltoketo; V Isomaa; O Mäentausta; R Vihko
Journal:  FEBS Lett       Date:  1988-10-24       Impact factor: 4.124

4.  Peroxisomal multifunctional enzyme of beta-oxidation metabolizing D-3-hydroxyacyl-CoA esters in rat liver: molecular cloning, expression and characterization.

Authors:  Y M Qin; M H Poutanen; H M Helander; A P Kvist; K M Siivari; W Schmitz; E Conzelmann; U Hellman; J K Hiltunen
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

5.  Activity of 17 beta-hydroxysteroid oxidoreductase in tissues of the human fetus.

Authors:  L Milewich; P C MacDonald; B R Carr
Journal:  J Endocrinol       Date:  1989-12       Impact factor: 4.286

6.  Estrogen formation in the early rabbit embryo.

Authors:  F W George; J D Wilson
Journal:  Science       Date:  1978-01-13       Impact factor: 47.728

7.  17 beta-Hydroxysteroid oxidoreductase: a ubiquitous enzyme. Interconversion of estrone and estradiol-17 beta in BALB/c mouse tissues.

Authors:  L Milewich; R L Garcia; L W Gerrity
Journal:  Metabolism       Date:  1985-10       Impact factor: 8.694

8.  Changing 17 beta-hydroxysteroid dehydrogenase activity in preimplantation rat and mouse embryos.

Authors:  J T Wu; P S Matsumoto
Journal:  Biol Reprod       Date:  1985-04       Impact factor: 4.285

9.  Molecular cloning and expression of an abundant rabbit ovarian protein with 20 alpha-hydroxysteroid dehydrogenase activity.

Authors:  W R Lacy; K J Washenick; R G Cook; B S Dunbar
Journal:  Mol Endocrinol       Date:  1993-01

10.  Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues.

Authors:  C Martel; E Rhéaume; M Takahashi; C Trudel; J Couët; V Luu-The; J Simard; F Labrie
Journal:  J Steroid Biochem Mol Biol       Date:  1992-03       Impact factor: 4.292

View more
  6 in total

Review 1.  Estrogen metabolism as a regulator of estrogen action in the mammary gland.

Authors:  M Miettinen; V Isomaa; H Peltoketo; D Ghosh; P Vihko
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

2.  The intraovarian actions of estrogen receptor-alpha are necessary to repress the formation of morphological and functional Leydig-like cells in the female gonad.

Authors:  John F Couse; Mariana M Yates; Karina F Rodriguez; Jo Anne Johnson; Donald Poirier; Kenneth S Korach
Journal:  Endocrinology       Date:  2006-04-20       Impact factor: 4.736

3.  Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression.

Authors:  Yumi Imai; Siobhan Boyle; Gladys M Varela; Emilie Caron; Xiaoyan Yin; Raina Dhir; Ravindra Dhir; Mark J Graham; Rexford S Ahima
Journal:  Physiol Genomics       Date:  2012-09-25       Impact factor: 3.107

4.  Unexpected virilization in male mice lacking steroid 5 alpha-reductase enzymes.

Authors:  M S Mahendroo; K M Cala; D L Hess; D W Russell
Journal:  Endocrinology       Date:  2001-11       Impact factor: 4.736

5.  The low gonadotropin-independent constitutive production of testicular testosterone is sufficient to maintain spermatogenesis.

Authors:  Fu-Ping Zhang; Tomi Pakarainen; Matti Poutanen; Jorma Toppari; Ilpo Huhtaniemi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-29       Impact factor: 11.205

6.  Overlapping dose responses of spermatogenic and extragonadal testosterone actions jeopardize the principle of hormonal male contraception.

Authors:  Olayiwola O Oduwole; Natalia Vydra; Nicholas E M Wood; Luna Samanta; Laura Owen; Brian Keevil; Mandy Donaldson; Kikkeri Naresh; Ilpo T Huhtaniemi
Journal:  FASEB J       Date:  2014-03-05       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.